Covid-19 Research

Original Article

OCLC Number/Unique Identifier: 9506589506

Analysis of Vitamin D and its Correlation with Interleukin-6 in COVID-19 Patients at Mary Begg Health Services, Zambia: Implication for Patient Management

Medicine Group    Start Submission

Misheck Chileshe*, Mwamba Mulamba, Vernon Julius, Mwenya Kwangu and Stephen Mwisiya Mubita

Volume3-Issue4
Dates: Received: 2022-04-08 | Accepted: 2022-04-15 | Published: 2022-04-16
Pages: 335-343

Abstract

Introduction: The emergence of SARS COV-2 and Coronavirus Disease 2019 (COVID-19) came without any known medication or treatment, thereby raising concerns for drug (therapeutics) research and development. Vitamin D is a potent immunomodulator with a proven protective effect against respiratory viral infections, and because of this, many studies have been carried out to evaluate the effects of vitamin D on COVID-19 infection, however, with varying conclusions.

Objective: To assess serum vitamin D levels and their correlation with IL-6 and other clinical characteristics among COVID-19 patients attended to at Mary Begg Health Services (MBHS).

Methods: This cross-sectional study was conducted among COVID-19 patients at MBHS. The study included 33 confirmed severe patients admitted to the intensive care unit, 45 patients with mild symptoms, and 45 healthy controls. The Kruskal–Wallis test was used to compare the median serum vitamin D levels among the three groups, and Spearman’s correlations were performed to assess the correlation between serum vitamin D, IL-6, and clinical characteristics of the patients.

Results: The majority of COVID-19 patients in this study had optimal levels of vitamin D 44/78 (56.4%), with vitamin D deficiency being observed in only 6/78 (7.7%). Vitamin D levels in the control group were not significantly different when compared to levels measured in severe and mild COVID-19 patients, median [IQR], 31.33 ng/ml [25.9-39.56] compared to 29.97 ng/ml [26.19-37.45] and 31.9 ng/ml [26.12-38.34], p = 0.916, respectively. Severe COVID-19 patients admitted to the intensive care unit were older and had median higher IL-6 levels (43.67 ± 11.86 years vs. 33.89 ± 13.38 years; p = 0.001 and 27.56 pg/ml [13.13-47.81] vs. 8.34 pg/ml [5.1-21.63]; p = 0.0003, respectively) than patients with mild disease. A significant negative correlation between vitamin D and IL-6 (r = - 0.42; p = 0.016) was found in severe COVID-19 patients.

Conclusion: A negative (inverse) correlation between serum vitamin D and IL-6 was found in this study. Therefore, patients with severe COVID-19 might benefit from vitamin D supplementation, which would help to downregulate the cytokine storm and hence reduced disease severity.

FullText HTML FullText PDF DOI: 10.37871/jbres1445


Certificate of Publication




Copyright

© 2022 Chileshe M, et al. Distributed under Creative Commons CC-BY 4.0

How to cite this article

Chileshe M, Mulamba M, Julius V, Kwangu M, Mubita SM. Analysis of Vitamin D and its Correlation with Interleukin-6 in COVID-19 Patients at Mary Begg Health Services, Zambia: Implication for Patient Management. J Biomed Res Environ Sci. 2022 Apr 13; 3(4): 335-343. doi: 10.37871/jbres1445, Article ID: JBRES1445, Available at: https://www.jelsciences.com/articles/jbres1445.pdf


Subject area(s)

References


  1. Chileshe M, Mupeta G, Kasanga M, Lindizyani Mfune R, Mudenda S, Biemba M, et al. Prevalence of Adverse Events Post-COVID-19 Vaccination amongst the Adult Zambian Population. J Biomed Res Environ Sci. 2021;2(12):1315-1321. doi: 10.37871/jbres1389.
  2. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23. PMID: 32282949; PMCID: PMC7262337.
  3. Padhi S, Suvankar S, Panda VK, Pati A, Panda AK. Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study. Int Immunopharmacol. 2020 Nov;88:107001. doi: 10.1016/j.intimp.2020.107001. Epub 2020 Sep 14. PMID: 33182040; PMCID: PMC7489890.
  4. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2020 Sep 1;3(9):e2019722. doi: 10.1001/jamanetworkopen.2020.19722. PMID: 32880651; PMCID: PMC7489852.
  5. Kazancioglu S, Yilmaz FM, Bastug A, Sakallı A, Ozbay BO, Buyuktarakci C, Bodur H, Yilmaz G. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunol. 2021 Jun;34(5):342-351. doi: 10.1089/vim.2020.0166. Epub 2020 Nov 23. PMID: 33264073.
  6. Xu Y, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, Lau E, Cao H. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020 Aug 26;18(1):322. doi: 10.1186/s12967-020-02488-5. PMID: 32847594; PMCID: PMC7447609.
  7. Adami G, Giollo A, Fassio A, Benini C, Bertoldo E, Bertoldo F, Orsolini G, Idolazzi L, Viapiana O, Giannini S, Passeri G, Tacconelli E, Micheletto C, Gatti D, Rossini M. Vitamin D and disease severity in coronavirus disease 19 (COVID-19). Reumatismo. 2021 Jan 18;72(4):189-196. doi: 10.4081/reumatismo.2020.1333. PMID: 33677945.
  8. Silberstein M. COVID-19 and IL-6: Why vitamin D (probably) helps but tocilizumab might not. Eur J Pharmacol. 2021 May 15;899:174031. doi: 10.1016/j.ejphar.2021.174031. Epub 2021 Mar 13. PMID: 33722593; PMCID: PMC7954769.
  9. Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther. 2020 Jul 25;5(1):128. doi: 10.1038/s41392-020-00243-2. PMID: 32712629; PMCID: PMC7381863.
  10. Honardoost M, Ghavideldarestani M, Khamseh ME. Role of vitamin D in pathogenesis and severity of COVID-19 infection. Arch Physiol Biochem. 2020 Oct 30:1-7. doi: 10.1080/13813455.2020.1792505. Epub ahead of print. PMID: 33125298.
  11. COVID-19 and social distancing. Can J Addict. 2020 Jun 3;11(2):4-6. doi: 10.1097/CXA.0000000000000081. PMID: 34192129; PMCID: PMC7309640.
  12. Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. medRxiv. 2020. doi: 10.1101/2020.04.08.20058578
  13. Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy. 2021 Jun;13(9):753-765. doi: 10.2217/imt-2020-0349. Epub 2021 Apr 28. PMID: 33906375; PMCID: PMC8080872.
  14. Visser MPJ, Dofferhoff ASM, van den Ouweland JMW, van Daal H, Kramers C, Schurgers LJ, Janssen R, Walk J. Corrigendum: Effects of Vitamin D and K on Interleukin-6 in COVID-19. Front Nutr. 2022 Mar 8;9:868324. doi: 10.3389/fnut.2022.868324. Erratum for: Front Nutr. 2022 Jan 17;8:761191. PMID: 35356738; PMCID: PMC8959105.
  15. Bayraktar N, Turan H, Bayraktar M, Ozturk A, Erdoğdu H. Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19. J Med Virol. 2022 Jan;94(1):154-160. doi: 10.1002/jmv.27294. Epub 2021 Aug 30. PMID: 34427934; PMCID: PMC8661791.
  16. Balzanelli MG, Distratis P, Lazzaro R, Cefalo A, Catucci O, Aityan SK, Dipalma G, Vimercati L, Inchingolo AD, Maggiore ME, Mancini A, Santacroce L, Gesualdo L, Pham VH, Iacobone D, Contaldo M, Serpico R, Scarano A, Lorusso F, Toai TC, Tafuri S, Migliore G, Inchingolo AM, Nguyen KCD, Inchingolo F, Tomassone D, Gargiulo Isacco C. The Vitamin D, IL-6 and the eGFR Markers a Possible Way to Elucidate the Lung-Heart-Kidney Cross-Talk in COVID-19 Disease: A Foregone Conclusion. Microorganisms. 2021 Sep 7;9(9):1903. doi: 10.3390/microorganisms9091903. PMID: 34576798; PMCID: PMC8464828.
  17. Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R. Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series. Am J Ther. 2020 Sep/Oct;27(5):e485-e490. doi: 10.1097/MJT.0000000000001222. PMID: 32804682; PMCID: PMC7473790.
  18. Hribar CA, Cobbold PH, Church FC. Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson's Disease. Brain Sci. 2020 May 8;10(5):284. doi: 10.3390/brainsci10050284. PMID: 32397275; PMCID: PMC7287983.
  19. Razdan K, Singh K, Singh D. Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation? Med Drug Discov. 2020 Sep;7:100051. doi: 10.1016/j.medidd.2020.100051. Epub 2020 Jun 2. PMID: 32835212; PMCID: PMC7266578.
  20. Campi I, Gennari L, Merlotti D, Mingiano C, Frosali A, Giovanelli L, Torlasco C, Pengo MF, Heilbron F, Soranna D, Zambon A, Di Stefano M, Aresta C, Bonomi M, Cangiano B, Favero V, Fatti L, Perego GB, Chiodini I, Parati G, Persani L. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect Dis. 2021 Jun 14;21(1):566. doi: 10.1186/s12879-021-06281-7. PMID: 34126960; PMCID: PMC8200788.
  21. Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep. 2020 Nov 19;10(1):20191. doi: 10.1038/s41598-020-77093-z. PMID: 33214648; PMCID: PMC7677378.
  22. Ricci A, Pagliuca A, D'Ascanio M, Innammorato M, De Vitis C, Mancini R, Giovagnoli S, Facchiano F, Sposato B, Anibaldi P, Marcolongo A, De Dominicis C, Laghi A, Muscogiuri E, Sciacchitano S. Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients. Respir Res. 2021 Mar 3;22(1):76. doi: 10.1186/s12931-021-01666-3. PMID: 33658032; PMCID: PMC7928197.
  23. Orrù B, Szekeres-Bartho J, Bizzarri M, Spiga AM, Unfer V. Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management? Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8187-8193. doi: 10.26355/eurrev_202008_22507. PMID: 32767348.
  24. Labudzynskyi D, Shymanskyy I, Veliky M. Role of vitamin D3 in regulation of interleukin-6 and osteopontin expression in liver of diabetic mice. Eur Rev Med Pharmacol Sci. 2016 Jul;20(13):2916-9. PMID: 27424994.
  25. Lohia P, Kapur S, Patel P, Seyoum B. Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients. Respir Res. 2021 Apr 9;22(1):102. doi: 10.1186/s12931-021-01703-1. PMID: 33832495; PMCID: PMC8032551.
  26. Hernández JL, Nan D, Fernandez-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M, Muñoz-Cacho P, Olmos JM, Gutiérrez-Cuadra M, Ruiz-Cubillán JJ, Crespo J, Martínez-Taboada VM. Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1343-e1353. doi: 10.1210/clinem/dgaa733. PMID: 33159440; PMCID: PMC7797757.
  27. Shekhawat J, Gauba K, Gupta S, Purohit P, Mitra P, Garg M, Misra S, Sharma P, Banerjee M. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm. Indian J Clin Biochem. 2021 Jun 21;36(4):1-11. doi: 10.1007/s12291-021-00989-8. Epub ahead of print. PMID: 34177139; PMCID: PMC8216093.
  28. Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020 Oct 1;40:37. doi: 10.1186/s41232-020-00146-3. PMID: 33014208; PMCID: PMC7527296.
  29. National Institutes of Health. Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19). Nih. 2021;2019:1-243.
  30. World Health Organisation. Therapeutics and COVID-19 LIVING GUIDELINE. 3 MARCH 2022. 2022;1-109.
  31. Daugaard S, Garde AH, Hansen ÅM, Vistisen HT, Rejnmark L, Kolstad HA. Indoor, outdoor, and night work and blood concentrations of vitamin D and parathyroid hormone. Scand J Work Environ Health. 2018 Nov 1;44(6):647-657. doi: 10.5271/sjweh.3745. Epub 2018 Jun 17. PMID: 29909424.
  32. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013 Jul 5;5(7):2502-21. doi: 10.3390/nu5072502. PMID: 23857223; PMCID: PMC3738984.
  33. Abraham J, Dowling K, Florentine S. Can Optimum Solar Radiation Exposure or Supplemented Vitamin D Intake Reduce the Severity of COVID-19 Symptoms? Int J Environ Res Public Health. 2021 Jan 16;18(2):740. doi: 10.3390/ijerph18020740. PMID: 33467131; PMCID: PMC7829816.
  34. Shahin W, Rabie W, Alyossof O, Alasiri M, Alfaki M, Mahmoud E, Hijazi M, Faraidi HE, Alahmari H. COVID-19 in children ranging from asymptomatic to a multi-system inflammatory disease: A single-center study. Saudi Med J. 2021 Mar;42(3):299-305. doi: 10.15537/smj.2021.42.3.20200625. PMID: 33632909; PMCID: PMC7989263.
  35. Peng MY, Liu WC, Zheng JQ, Lu CL, Hou YC, Zheng CM, Song JY, Lu KC, Chao YC. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D. Int J Mol Sci. 2021 May 16;22(10):5251. doi: 10.3390/ijms22105251. PMID: 34065735; PMCID: PMC8155889.
  36. Oristrell J, Oliva JC, Subirana I, Casado E, Domínguez D, Toloba A, Aguilera P, Esplugues J, Fafián P, Grau M. Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study. Biomedicines. 2021 May 5;9(5):509. doi: 10.3390/biomedicines9050509. PMID: 34063015; PMCID: PMC8147982.
  37. Phosri A, Cao Y, Harada Sassa M, Harada KH. Socio-economic factors do also matter: comments on the article "Can climatic factors explain the differences in COVID-19 incidence and severity across the spanish regions?: an ecological study". Environ Health. 2021 Feb 18;20(1):17. doi: 10.1186/s12940-021-00701-6. PMID: 33602202; PMCID: PMC7891113.
  38. Exploring links between Vitamin D deficiency and covid-19. PLoS Pathog. 2020;16(9):1–7.
  39. Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020 Jul;32(7):1195-1198. doi: 10.1007/s40520-020-01570-8. Epub 2020 May 6. PMID: 32377965; PMCID: PMC7202265.
  40. Vasheghani M, Jannati N, Baghaei P, Rezaei M, Aliyari R, Marjani M. The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality. Sci Rep. 2021 Sep 2;11(1):17594. doi: 10.1038/s41598-021-97017-9. PMID: 34475485; PMCID: PMC8413335.
  41. Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging". Inflamm Res. 2020 Sep;69(9):825-839. doi: 10.1007/s00011-020-01372-8. Epub 2020 Jun 11. PMID: 32529477; PMCID: PMC7289226.
  42. Pawelec G. T-cell immunity in the aging human. Haematologica. 2014;99(5):795-797. doi: 10.3324/haematol.2013.094383
  43. O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021 Feb;590(7844):140-145. doi: 10.1038/s41586-020-2918-0. Epub 2020 Nov 2. PMID: 33137809.
  44. Sovran B, Hugenholtz F, Elderman M, Van Beek AA, Graversen K, Huijskes M, Boekschoten MV, Savelkoul HFJ, De Vos P, Dekker J, Wells JM. Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity. Sci Rep. 2019 Feb 5;9(1):1437. doi: 10.1038/s41598-018-35228-3. PMID: 30723224; PMCID: PMC6363726.
  45. Arumugam VA, Thangavelu S, Fathah Z, Ravindran P, Sanjeev AMA, Babu S, Meyyazhagan A, Yatoo MI, Sharun K, Tiwari R, Pandey MK, Sah R, Chandra R, Dhama K. COVID-19 and the world with co-morbidities of heart disease, hypertension and diabetes. J Pure Appl Microbiol. 2020;14(3):1623-1638. Doi: 10.22207/JPAM.14.3.01
  46. Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, Seidu S, Zaccardi F, Davies MJ, Khunti K. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020 Oct;22(10):1915-1924. doi: 10.1111/dom.14124. Epub 2020 Jul 16. PMID: 32573903; PMCID: PMC7361304.
  47. Mardani R, Ahmadi Vasmehjani A, Zali F, Gholami A, Mousavi Nasab SD, Kaghazian H, Kaviani M, Ahmadi N. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020 Apr 4;8(1):e43. PMID: 32259132; PMCID: PMC7130449.
  48. Seyit M, Avci E, Nar R, Senol H, Yilmaz A, Ozen M, Oskay A, Aybek H. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021 Feb;40:110-114. doi: 10.1016/j.ajem.2020.11.058. Epub 2020 Dec 6. PMID: 33309506; PMCID: PMC7719281.
  49. Cao W, Shi L, Chen L, Xu X, Wu Z. Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. medRxiv. 2020. doi: 10.1101/2020.02.23.20026963
  50. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020 May 24;8:36. doi: 10.1186/s40560-020-00453-4. PMID: 32483488; PMCID: PMC7245646.
  51. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020 May 24;8:36. doi: 10.1186/s40560-020-00453-4. PMID: 32483488; PMCID: PMC7245646.
  52. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, Wang Q, Miao H. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4. Erratum in: Signal Transduct Target Ther. 2020 Apr 29;5(1):61. PMID: 32296069; PMCID: PMC7100419.
  53. Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17. PMID: 32203186; PMCID: PMC7091621.
  54. Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3. PMID: 32458561; PMCID: PMC7283672.
  55. Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett. 2020 Sep;225:31-32. doi: 10.1016/j.imlet.2020.06.013. Epub 2020 Jun 20. PMID: 32569607; PMCID: PMC7305732.
  56. Alipio M. Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-2019). SSRN Electron J. 2020;2019(082):1-6.
  57. Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017 Jan;27(1). doi: 10.1002/rmv.1909. Epub 2016 Oct 7. PMID: 27714929.
  58. Gaudio A, Murabito AR, Agodi A, Montineri A, Castellino P, D O CoV Research. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. Int J Environ Res Public Health. 2021 Mar 27;18(7):3491. doi: 10.3390/ijerph18073491. PMID: 33801759; PMCID: PMC8036292.
  59. Samanta S. Vitamin D and immunomodulation in the skin: a useful affirmative nexus. Explor Immunol. 2021;90-111. doi: 10.37349/ei.2021.00009
  60. Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008 May-Jun;84(3):539-49. doi: 10.1111/j.1751-1097.2007.00226.x. PMID: 18435612; PMCID: PMC2671032.
  61. Islam MT, Salehi B, Karampelas O, Sharifi-Rad J, Docea AO, Martorell M, Calina D. High skin melanin content, vitamin D deficiency and immunity: Potential interference for severity of COVID-19. Farmacia. 2020;68(6):970-983. https://bit.ly/3KGa0tm
  62. Alipio MM. Do latitude and ozone concentration predict Covid-2019 cases in 34 countries? medRxiv. 2020;63(082):1-9. doi: 10.1101/2020.04.09.20060202
  63. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009 Apr 1;182(7):4289-95. doi: 10.4049/jimmunol.0803736. PMID: 19299728; PMCID: PMC2683618.
  64. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007 Aug 15;179(4):2060-3. doi: 10.4049/jimmunol.179.4.2060. PMID: 17675463.
  65. Djibo DA, Sahr F, McCutchan JA, Jain S, Araneta MRG, Brodine SK, Shaffer RA. Prevalence and Risk Factors for Human Immunodeficiency Virus (HIV) and Syphilis Infections Among Military Personnel in Sierra Leone. Curr HIV Res. 2017;15(2):128-136. doi: 10.2174/1570162X15666170517101349. PMID: 28521722.
  66. Cimmino G, Conte S, Morello M, Pellegrino G, Marra L, Morello A, Nicoletti G, De Rosa G, Golino P, Cirillo P. Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection? J Cardiovasc Dev Dis. 2022 Jan 13;9(1):27. doi: 10.3390/jcdd9010027. PMID: 35050236; PMCID: PMC8781542.
  67. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, Goleva E. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012 Mar 1;188(5):2127-35. doi: 10.4049/jimmunol.1102412. Epub 2012 Feb 1. PMID: 22301548; PMCID: PMC3368346.


Comments


Swift, Reliable, and studious. We aim to cherish the world by publishing precise knowledge.

  • asd
  • Brown University Library
  • University of Glasgow Library
  • University of Pennsylvania, Penn Library
  • University of Amsterdam Library
  • The University of British Columbia Library
  • UC Berkeley’s Library
  • MIT Libraries
  • Kings College London University
  • University of Texas Libraries
  • UNSW Sidney Library
  • The University of Hong Kong Libraries
  • UC Santa Barbara Library
  • University of Toronto Libraries
  • University of Oxford Library
  • Australian National University
  • ScienceOpen
  • UIC Library
  • KAUST University Library
  • Cardiff University Library
  • Ball State University Library
  • Duke University Library
  • Rutgers University Library
  • Air University Library
  • UNT University of North Texas
  • Washington Research Library Consortium
  • Penn State University Library
  • Georgetown Library
  • Princeton University Library
  • Science Gate
  • Internet Archive
  • WashingTon State University Library
  • Dimensions
  • Zenodo
  • OpenAire
  • Index Copernicus International
  • icmje
  •  International Scientific Indexing (ISI)
  • Sherpa Romeo
  • ResearchGate
  • Universidad De Lima
  • WorldCat
  • JCU Discovery
  • McGill
  • National University of Singepore Libraries
  • SearchIT
  • Scilit
  • SemantiScholar
  • Base Search
  • VU
  • KB
  • Publons
  • oaji
  • Harvard University
  • sjsu-library
  • UWLSearch
  • Florida Institute of Technology
  • CrossRef
  • LUBsearch
  • Universitat de Paris
  • Technical University of Denmark
  • ResearchBIB
  • Google Scholar
  • Microsoft Academic Search